Evidence map›Paper›PMID 37118734›Full record

ArticleBMC medical genomics2023

Apoptosis related genes mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide immunotherapy in bladder cancer.

Liquan Zhou, Guanglong Xu, Fu Huang, Wenyuan Chen, Jiange Zhang, Yong Tang

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Liquan Zhou *Department of Urology, The Second Affiliated Hospital, Guangxi Medical University, Nanning, 530006, Guangxi, China.
Guanglong Xu *Department of Urology, The Second Affiliated Hospital, Guangxi Medical University, Nanning, 530006, Guangxi, China.
Fu HuangDepartment of Urology, The Second Affiliated Hospital, Guangxi Medical University, Nanning, 530006, Guangxi, China.
Wenyuan ChenDepartment of Urology, The Second Affiliated Hospital, Guangxi Medical University, Nanning, 530006, Guangxi, China.
Jiange ZhangDepartment of Urology, The Second Affiliated Hospital, Guangxi Medical University, Nanning, 530006, Guangxi, China.
Yong Tang *Department of Urology, Wuming Hospital, Guangxi Medical University, Nanning, 530199, Guangxi, China. yongttang@126.com.
Guangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apoptosis has been discovered as a mechanism of cell death. The purpose of this study is to identify the diagnostic signature factors related to bladder cancer (BLCA) through apoptosis related genes (ARGs). Clinicopathological parameters and transcriptomics data of 1,440 BLCA patients were obtained from 7 datasets (GSE13507, GSE31684, GSE32548, GSE32894, GSE48075, TCGA-BLCA, and IMvigor210). We first identified prognosis-related ARGs in BLCA and used them to construct two ARGs molecular subtypes by using consensus clustering algorithm. By using principal component analysis algorithms, a ARGscore was constructed to quantify the index of individualized patient. High ARGscore correlated with progressive malignancy and poor outcomes in BLCA patients. High ARGscore was associated with higher immune cell, higher estimate scores, higher stromal scores, higher immune scores, higher immune checkpoint, and lower tumor purity, which was consistent with the "immunity tidal model theory". Preclinically, BLCA immunotherapy cohorts confirmed patients with low ARGscore demonstrated significant therapeutic advantages and clinical benefits. These findings contribute to our understanding of ARGs and immunotherapy in BLCA. The ARGscore is a potentially useful tool to predict the prognosis and immunotherapy in BLCA.

Indexed as

Tumor MicroenvironmentUrinary Bladder NeoplasmsAlgorithmsApoptosisHumansImmunotherapyPrognosisApoptosisBladder cancerImmunotherapyScoring systemTumor microenvironment

Identifiers

PMID37118734
PMCPMC10148450
OpenAlexW4367310353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.